Covered recipient · General Payments record
CHRISTI A WITHERSPOON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,175.46
- Reported across 252 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $602.46 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.43 | 15 |
| Acerta Pharma LLC | $146.16 | 2 |
| Novo Nordisk AS | $69.17 | 3 |
| GlaxoSmithKline, LLC. | $64.40 | 3 |
| PFIZER INC. | $41.31 | 2 |
| Ethicon Inc. | $36.63 | 1 |
| Dynavax Technologies Corporation | $35.04 | 2 |
| Lilly USA, LLC | $17.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.83 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350744 | CMS |
| ABBVIE INC. | $3.02 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350746 | CMS |
| ABBVIE INC. | $13.32 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350748 | CMS |
| ABBVIE INC. | $17.16 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350750 | CMS |
| ABBVIE INC. | $24.67 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350752 | CMS |
| ABBVIE INC. | $32.24 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350754 | CMS |
| ABBVIE INC. | $2.55 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350756 | CMS |
| ABBVIE INC. | $15.03 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350758 | CMS |
| ABBVIE INC. | $17.92 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350760 | CMS |
| ABBVIE INC. | $1.96 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350762 | CMS |
| ABBVIE INC. | $24.00 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350764 | CMS |
| ABBVIE INC. | $13.56 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350766 | CMS |
| ABBVIE INC. | $2.80 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350768 | CMS |
| ABBVIE INC. | $12.40 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350770 | CMS |
| ABBVIE INC. | $4.97 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350772 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.83 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105523155 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.33 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104308286 | CMS |
| Dynavax Technologies Corporation | $22.98 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082148941 | CMS |
| Dynavax Technologies Corporation | $12.06 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082149573 | CMS |
| Ethicon Inc. | $36.63 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077584706 | CMS |
| GlaxoSmithKline, LLC. | $23.21 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116595677 | CMS |
| GlaxoSmithKline, LLC. | $22.18 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116445540 | CMS |
| GlaxoSmithKline, LLC. | $19.01 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116479611 | CMS |
| Lilly USA, LLC | $17.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136099740 | CMS |
| Novo Nordisk Inc | $21.23 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097540875 | CMS |
| Novo Nordisk Inc | $23.48 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097675176 | CMS |
| Novo Nordisk Inc | $24.46 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096853505 | CMS |
| PFIZER INC. | $20.04 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131502528 | CMS |
| PFIZER INC. | $21.27 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243175 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.